Please ensure Javascript is enabled for purposes of website accessibility

Marijuana Stock Cresco Labs Slips on Q4 Results

By Eric Volkman - Mar 25, 2021 at 5:31PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Collectively, analysts were looking for a net profit instead of the $24 million-plus loss the company announced.

Cresco Labs (CRLBF -2.35%) wasn't exactly a marijuana stock on fire Thursday, following the release of fiscal fourth-quarter 2020 results that left investors cold.

The quarter saw the multi-state operator (MSO) earn $162.3 million, a 6% improvement over the previous quarter and nearly four times higher than the Q4 2019 result. Cresco didn't hesitate to mention that this was a new record Q4 high for the company.

Marijuana flowers atop a collection of US currency.

Image source: Getty Images.

It didn't similarly emphasize its bottom-line result, as this was a loss of nearly $24.4 million. That compared unfavorably to the previous quarter's $4.9 million profit, although it was far better than the year-ago deficit of $45.2 million.

While the company slightly exceeded the average analyst estimate of $161.4 million for revenue, it fell short of the anticipated $0.02 per share net profit.

Cresco is a frequent and eager acquirer of assets, which gives the company greater scale and drives that revenue figure higher. But of course, acquisitions and expansions cost money, and such activities contributed strongly to the Q4 bottom-line loss. Cresco has ambitions to be an important player throughout the U.S., which remains a patchwork of states that have not legalized marijuana, or have done so fully or partially.

That said, the company is doing well in its mission to expand its footprint and has relatively good positions in markets that are currently fully legal (like its home state of Illinois, for one) and those that soon will be (like New York). Investors who believe American cannabis retail has a future shouldn't be discouraged by Cresco's mixed Q4.

Some are heading for the exits, though. On Thursday, in contrast to the 0.5% rise of the S&P 500 index, Cresco stock fell by 1.3%.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Cresco Labs Inc. Stock Quote
Cresco Labs Inc.
CRLBF
$3.74 (-2.35%) $0.09

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning service.

Stock Advisor Returns
344%
 
S&P 500 Returns
120%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 05/27/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.